Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trusopt for Cystoid Macular Edema in Retinal Degeneration
NCT00716586Phase 4Completed
- Sponsor
- University of Illinois Chicago
- Start
- Oct 2005
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dorzolamide in cystoid macular edema (CME), sponsored by University of Illinois Chicago. Started Oct 2005; status: completed.
02
Drugs
dorzolamide
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT00716586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00716586.